Monthly Spotlight on Fraud, Waste, and Abuse

Why This Topic Matters

The article helps compliance-focused readers track current enforcement trends, understand the kinds of behaviors that trigger investigations, and stay aware of issues that may affect billing integrity, provider relationships, and government program oversight.

Article Sections

1. Oncology Practice, Physicians, and Reference Laboratory to Pay Over $4 Million to Settle False Claims Act Allegations

   Summarizes an enforcement matter involving an oncology practice, affiliated physicians, and a reference laboratory. The section discusses alleged program integrity issues, settlement activity, and related government oversight themes.

2. Owner of Telemedicine Companies Pleads Guilty to $110 Million Medicare Fraud Scheme

   Covers a criminal case involving telemedicine-related companies and Medicare fraud allegations tied to durable medical equipment. The section focuses on the investigation, plea outcome, and sentencing context.

3. Telemedicine Nurse Practitioner Sentenced for $7.8 Million Durable Medical Equipment Fraud Scheme

   Describes a sentencing in a telemedicine-related case involving durable medical equipment claims. The section outlines the enforcement action, criminal resolution, and restitution information.

4. Two Doctors Sentenced for $4M Fraudulent Urine Drug Testing Scheme

   Summarizes a case involving urine drug testing, insurance billing, and criminal sentencing. The section highlights the roles of clinic leadership and the broader enforcement outcome.

5. False Claims Act Complaint Filed Against Regeneron Pharmaceuticals for Fraudulent Drug Pricing Reporting

   Reviews a False Claims Act complaint concerning pharmaceutical pricing reporting and Medicare reimbursement. The section addresses the allegations, government claims, and whistleblower-related aspects.